ATLAS CROSSING LLC

Lobbying for NOVOZYMES NORTH AMERICA INC. · Biosolutions company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · North Carolina · House · Senate · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Health Issues

Issues related to the expansion of HSA for dietary supplements. Issues related to the benefits of dietary supplements. Issues related to the Generally Recognized as Safe designation. Issues related to dietary supplements and the WIC program.

Food Industry (safety, labeling, etc.)

Issues related to allowance of dietary supplements in the WIC program. FY27 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.